In Vitro Evaluations of Hexokinase-2 Inhibition with 3-Bromopyruvate Encapsulated in Targeted Liposomal Formulations using 3D Spheroid Models of Tumor Aerobic Glycolysis

Text Registration

In Vitro Evaluations of Hexokinase-2 Inhibition with 3-Bromopyruvate Encapsulated in Targeted Liposomal Formulations using 3D Spheroid Models of Tumor Aerobic Glycolysis

Status

Published

on 7 Jul 2016

Year of Creation

2014

Srujan Kumar Gandham

Registration Number

TX0008252138

on 7 Jul 2016

The U.S. Copyright record (Registration Number: TX0008252138) dated 7 Jul 2016, pertains to an electronic file (eService) titled "In Vitro Evaluations of Hexokinase-2 Inhibition with 3-Bromopyruvate Encapsulated in Targeted Liposomal Formulations using 3D Spheroid Models of Tumor Aerobic Glycolysis" created in 2014. The copyright holder is Srujan Kumar Gandham, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Srujan Kumar Gandham.

Srujan Kumar Gandham

Application Details

Registration Number

TX0008252138

Registration Date

7/7/2016

Year of Creation

2014

Agency Marc Code

DLC-CO

Record Status

New

Physical Description

Electronic file (eService)

First Publication Nation

United States

Personal Authors

Srujan Kumar Gandham

Notes

Rights Note: Diana G Zajic, ProQuest-CSA, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600 xext77020, disspub@proquest.com

Statements

Application Title Statement: In Vitro Evaluations of Hexokinase-2 Inhibition with 3-Bromopyruvate Encapsulated in Targeted Liposomal Formulations using 3D Spheroid Models of Tumor Aerobic Glycolysis

Author Statement: Srujan Kumar Gandham Citizenship: United States Authorship: text

Notes

Rights Note: Diana G Zajic, ProQuest-CSA, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600 xext77020, disspub@proquest.com

Statements

Application Title Statement: In Vitro Evaluations of Hexokinase-2 Inhibition with 3-Bromopyruvate Encapsulated in Targeted Liposomal Formulations using 3D Spheroid Models of Tumor Aerobic Glycolysis

Author Statement: Srujan Kumar Gandham Citizenship: United States Authorship: text

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.